Top

Published in:

01-07-2015 | Case Report

Contralateral osteonecrosis of the femoral head newly developed after increasing the dose of corticosteroids

Authors: Kazuhiko Sonoda, Takuaki Yamamoto, Goro Motomura, Ryosuke Yamaguchi, Kazuyuki Karasuyama, Yukihide Iwamoto

Published in: Journal of Orthopaedic Science | Issue 4/2015

Excerpt

Nontraumatic osteonecrosis of the femoral head (ONFH) is a debilitating disorder that commonly affects 30- to 50-year-old individuals, with corticosteroid use being one of the major causative factors [1]. Although the precise pathogenesis of corticosteroid-induced ONFH remains unclear, both high-dose oral corticosteroid therapy and corticosteroid pulse treatment have been reported to be risk factors, highlighting the importance of the dose of corticosteroids in the development of corticosteroid-induced osteonecrosis [2‐7]. …

Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24.PubMedCentralPubMedCrossRef

Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, Moriya H. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60:1145–8.PubMedCentralPubMedCrossRef

Nakamura J, Saisu T, Yamashita K, Suzuki C, Kamegawa M, Takahashi K. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study. Arthritis Rheumatol. 2010;62:609–15.CrossRef

Aranow C, Zelicof S, Leslie D, Solomon S, Barland P, Norman A, Klein R, Weinstein A. Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol. 1997;24:2318–22.PubMed

Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997;24:654–62.PubMed

Yamaguchi R, Yamamoto T, Motomura G, Ikemura S, Iwamoto Y. Incidence of nontraumatic osteonecrosis of the femoral head in the Japanese population. Arthritis Rheumatol. 2011;63:3169–73.CrossRef

Massardo L, Jacobeli S, Leissner M, Gonzalez M, Villarroel L, Rivero S. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Lupus. 1992;1:401–5.PubMedCrossRef

Sugano N, Nishii T, Shibuya T, Nakata K, Masuhara K, Takaoka K. Contralateral hip in patients with unilateral nontraumatic osteonecrosis of the femoral head. Clin Orthop Relat Res. 1997;334:85–90.PubMed

Nakamura J, Ohtori S, Sakamoto M, Chuma A, Abe I, Shimizu K. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence. Clin Exp Rheumatol. 2010;28:13–8.PubMed

10.

Yamamoto T, DiCarlo EF, Bullough PG. The prevalence and clinicopathological appearance of extension of osteonecrosis in the femoral head. J Bone Joint Surg Br. 1999;81:328–32.PubMed

11.

Yang N, Ray DW, Matthews LC. Current concepts in glucocorticoid resistance. Steroids. 2012;77:1041–9.PubMedCrossRef

12.

Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med. 1995;181:33–40.PubMedCrossRef

13.

Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K, Takaoka K. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther. 2006;80:396–402.PubMedCrossRef

14.

Masada T, Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Ohashi H, Takaoka K. Increased hepatic cytochrome P450 3A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res. 2008;26:91–5.PubMedCrossRef

Title: Contralateral osteonecrosis of the femoral head newly developed after increasing the dose of corticosteroids
Authors: Kazuhiko Sonoda
Takuaki Yamamoto
Goro Motomura
Ryosuke Yamaguchi
Kazuyuki Karasuyama
Yukihide Iwamoto
Publication date: 01-07-2015
Publisher: Springer Japan
Published in: Journal of Orthopaedic Science / Issue 4/2015
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI: https://doi.org/10.1007/s00776-014-0541-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Contralateral osteonecrosis of the femoral head newly developed after increasing the dose of corticosteroids

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2015

Modification of spinal pedicle screw-plate fixation for bilateral pediatric pelvic ring injury in 2-year-old girl

Quadriceps tendon pie-crusting release of stiff knees in total knee arthroplasty

Clinical and radiographic outcomes of femoral head fractures: excision vs. fixation of fragment in Pipkin type I: what is the optimal choice for femoral head fracture?

Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats

Falls in patients after total hip arthroplasty in Japan

The NMatrix, a new method of presenting statistics, displays the characteristics of medicines with similar effects used in the treatment of lumbar spinal stenosis concisely and clearly, facilitating the selection of appropriate medications